Saitama Medical University, Japan
Shigehiro Katayama, M.D., Ph.D. has been Director of Saitama Medical University Hospital since 2008 and the Deputy Head from 2002 to 2008. He is currently Director Saitama Medical University Kawagoe Clinic since 2014. He also has been the Professor and the Head of Endocrinology and Diabetes Division at Faculty of Medicine, Saitama Medical University since 1995 and retired to be Emeritus Professor in 2015.
He graduated from Faculty of Medicine, The University of Tokyo and received M.D. degree in 1973 and Ph.D. degree in 1980 from The University of Tokyo. He was Postdoctoral Research Fellow at the Rockfeller University in 1980 and Assitant Professor at the State University of New York at Buffalo from 1981-1983. He moved to Saitama Medical University in 1983.
His research interests are in hypertension in diabetics in relation to effects of hypoglycemic and/or hypotensive agents on insulin resistance and in relation to diabetic nephropathy. He has been the Member of New Drug Approval Advisory Committee at The Department of Health and Welfare since 1993. He was a member of the committee to decide the drug price and the committee to approve a new drug, PMDA. He is now serving as one of the Program Officers in the field of Circulatory Disease and Diabetes Mellitus, Japan Agency fpr Medical Research and Development (AMED). He is a Board Certified Member of Japanese Society of Internal Medicine, Japan Endocrine Society, Japanese Society of Nephrology, Japanese Society of Hypertension, Japanese Society of Diabetes and a Fellow of American Diabetes Association, American Heart Association (High Blood Pressure Council).
He recieved Expert Investigator Award from the Japanese Society of Diabetic Complications in 2012, and Society Award from the Japanese Society of Hypertension in 2013.